Glen Eagle Advisors, LLC Voyager Therapeutics, Inc. Transaction History

Glen Eagle Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Aug 13, 2024	SELL	$4.61 - $9.04 $461 - $903	-100 Closed	0 $0
Q4 2020 Aug 13, 2024	BUY	$7.15 - $12.28 $715 - $1,228	100 New	100 $715,000
Q1 2019 Aug 13, 2024	BUY	$8.0 - $19.66 $800 - $1,966	100 New	100 $1.91 Million
Q3 2018 Aug 13, 2024	BUY	$17.11 - $21.74 $3,849 - $4,891	225 New	225 $4.26 Million
Q4 2016 Aug 12, 2024	BUY	N/A	500	500 $6.37 Million

130

34.7M

39.7K

34.6K

Ticker VYGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,647,600
Market Cap $219M
Description
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...

Get notified when there are updates to the investment portfolio of Glen Eagle Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Glen Eagle Advisors, LLC with notifications on news.